PatchSiren cyber security CVE debrief
CVE-2026-14959 IBM CVE debrief
AI-assisted PatchSiren debrief based on the supplied source corpus. The CVE record was published on 2026-07-28T21:17:26.443Z and has not been modified since then. The vulnerability affects IBM Aspera Faspex 5 versions 5.0.0 through 5.0.15.4, allowing remote authenticated attackers to execute arbitrary code due to shell command injection. Organizations should prioritize patching due to the critical severity of this vulnerability and potential impact on system security and data integrity. Evidence is limited to CVE and NVD details. Defenders should verify system logs for suspicious activity related to command injection and review system configurations for potential vulnerabilities. The CVSS score is 9.1, indicating critical severity.
- Vendor
- IBM
- Product
- Aspera Faspex 5
- CVSS
- CRITICAL 9.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-07-28
- Original CVE updated
- 2026-08-05
- Advisory published
- 2026-07-28
- Advisory updated
- 2026-08-05
Who should care
Organizations using IBM Aspera Faspex 5 versions 5.0.0 through 5.0.15.4 should be aware of this critical vulnerability and take immediate action to patch or mitigate the risk. System administrators, security teams, and IT managers responsible for these systems should prioritize patching due to the critical severity of this vulnerability and potential impact on system security and data integrity.
Technical summary
IBM Aspera Faspex 5 versions 5.0.0 through 5.0.15.4 are vulnerable to shell command injection, allowing remote authenticated attackers to execute arbitrary code. The vulnerability has a CVSS score of 9.1 and is classified as critical. Affected systems should be reviewed for exposure and patched or mitigated promptly.
Defensive priority
Organizations using IBM Aspera Faspex 5 versions 5.0.0 through 5.0.15.4 should prioritize patching due to the critical severity of this vulnerability.
Recommended defensive actions
- Apply patches or updates provided by IBM to address the shell command injection vulnerability in Aspera Faspex 5.
- Restrict access to sensitive areas of the system to authenticated users only.
- Monitor system logs for suspicious activity related to command injection.
Evidence notes
The CVE description indicates that IBM Aspera Faspex 5 5.0.0 through 5.0.15.4 could allow a remote authenticated attacker to execute arbitrary code due to shell command injection. The CVSS score is 9.1, indicating critical severity. Evidence is limited to CVE and NVD details. Defenders should verify system logs for suspicious activity related to command injection and review system configurations for potential vulnerabilities.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-14959 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-14959
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-14959 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-14959
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Mitigation or vendor reference
Unverified legacy reference
URL: https://www.ibm.com/support/pages/node/7280530
[email protected] - Vendor Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.